Deep Learning in Diagnostics Market Report 2026

The deep learning in diagnostics market size has grown exponentially in recent years. It will grow from $3.49 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 35.9%. The growth in the historic period can be attributed to increasing digitization of medical imaging, rising diagnostic workload pressures, expansion of radiology and pathology services, growing availability of annotated medical datasets, increasing adoption of clinical decision support.

The deep learning in diagnostics market size is expected to see exponential growth in the next few years. It will grow to $16.06 billion in 2030 at a compound annual growth rate (CAGR) of 35.7%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investment in ai-powered diagnostics, expansion of cloud-based diagnostic platforms, growing regulatory approvals for ai tools, increasing focus on workflow automation in healthcare. Major trends in the forecast period include increasing adoption of AI-based medical imaging analysis, growing use of deep learning in disease detection, expansion of automated diagnostic workflows, rising integration of multi-modal clinical data, enhanced focus on diagnostic accuracy.

The growing digitization of healthcare is expected to drive the expansion of the deep learning in diagnostics market in the coming years. Healthcare digitization involves the adoption of digital technologies within healthcare systems to improve efficiency, accessibility, data management, and overall patient care. This trend is fueled by the need to effectively manage and securely exchange the rapidly increasing volumes of patient data, supporting better care coordination and informed decision-making. The digitization process generates vast amounts of data from medical imaging, electronic health records, and connected devices, creating demand for deep learning in diagnostics, which can efficiently analyze this data and provide faster, more accurate insights than traditional methods. For example, in April 2023, FAIR Health Inc., a U.S.-based non-profit, reported a 7.3% national increase in telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. This growth in healthcare digitization is therefore driving the deep learning in diagnostics market.

Leading companies in the deep learning in diagnostics market are focusing on advanced AI-powered solutions to improve diagnostic accuracy, speed, and personalized patient care. AI-driven deep learning solutions use artificial intelligence and multi-layered neural networks to automatically analyze complex medical data, identify patterns, and generate highly accurate diagnostic insights with minimal human intervention. For instance, in May 2025, GE Healthcare Technologies Inc., a U.S.-based medical technology and diagnostics company, launched CleaRecon DL, designed to enhance image reconstruction and diagnostic precision. The system improves cone-beam CT (CBCT) images by effectively removing streak artifacts, producing clearer and more accurate imaging for interventional procedures. Clinical studies showed 98% clearer images and a 94% increase in clinician confidence, ultimately supporting better patient outcomes through streamlined workflows and more precise, image-guided treatments.

In April 2024, GE HealthCare, a U.S.-based provider of medical imaging devices, pharmaceutical diagnostics, and digital health solutions, acquired MIM Software for an undisclosed amount. This acquisition strengthens GE HealthCare’s AI-powered diagnostics and precision-care capabilities by integrating MIM Software’s advanced medical imaging analytics and workflow solutions across oncology, neurology, urology, and cardiology. MIM Software, based in the U.S., provides multimodal medical imaging analysis software, including tools for diagnostic imaging, radiation oncology treatment planning, molecular imaging, and digital workflow management for hospitals, imaging centers, and research institutions.

Major companies operating in the deep learning in diagnostics market are International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Tempus AI Inc., Qure.ai Technologies Pvt. Ltd., Freenome Holdings Inc., PathAI Inc., Aidoc Medical Ltd., Viz.ai Inc., SOPHiA GENETICS SA, Lunit Inc., Paige.AI Inc., Beijing Infervision Technology Co. Ltd., Indica Labs Inc., CureMetrix Inc., Deep Bio Inc., Enlitic Inc., ScreenPoint Medical B.V., VUNO Inc., Mindpeak GmbH, Arterys Inc.

North America was the largest region in the deep learning in diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep learning in diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep learning in diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the deep learning in diagnostics market by increasing costs of imported GPUs, imaging hardware, data storage systems, and specialized computing infrastructure. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported high-performance hardware, while Asia-Pacific faces higher costs for ai system exports. These tariffs are raising deployment costs and slowing technology upgrades. However, they are also encouraging domestic hardware production, localized ai model development, and regional innovation in diagnostic software solutions.

The deep learning in diagnostics market research report is one of a series of new reports that provides deep learning in diagnostics market statistics, including deep learning in diagnostics industry global market size, regional shares, competitors with a deep learning in diagnostics market share, detailed deep learning in diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the deep learning in diagnostics industry. This deep learning in diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Deep learning in diagnostics involves the application of advanced artificial intelligence techniques, particularly multi-layered neural networks, to analyze complex medical data such as images, signals, or patient records. It aids in identifying patterns, detecting diseases, predicting outcomes, and supporting clinical decision-making with greater speed and accuracy compared to traditional methods.

The key components of deep learning in diagnostics include software, hardware, and services. Software consists of programs, instructions, or data that guide a computer or device to perform specific tasks and can be deployed via cloud-based or on-premises methods. These solutions are applied across areas such as medical imaging, pathology, genomics, drug discovery, and more, serving end-users including hospitals, diagnostic laboratories, research institutes, and other healthcare organizations.

The deep learning in diagnostics market includes revenues earned by entities by providing services such as customized algorithm development services, real-time diagnostic monitoring services, genomic and biomarker analysis services, patient data integration and interpretation services, and disease risk prediction services. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep learning in diagnostics market also consists of sales of graphics processing units, edge AI devices, AI-enhanced CT scanners, and ultrasound devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.